Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1988-1-25
|
pubmed:abstractText |
Although 'chronic asthma' is a loosely defined disease, it may be equated approximately with non-allergic or 'intrinsic' asthma arising in adult life. In patients with this condition anticholinergic agents, particularly ipratropium bromide, have been shown to have a useful and rather prolonged bronchodilator action. This bronchodilatation approaches that achieved by therapeutic doses of Beta-agonists and is not associated with undesirable effects such as difficulty in sputum clearance. In conclusion anticholinergic agents are a safe and useful adjunct to other bronchodilators in patients with chronic asthma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0032-5473
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
63 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
41-6
|
pubmed:dateRevised |
2009-10-22
|
pubmed:meshHeading |
pubmed-meshheading:2962073-Administration, Inhalation,
pubmed-meshheading:2962073-Adult,
pubmed-meshheading:2962073-Asthma,
pubmed-meshheading:2962073-Atropine Derivatives,
pubmed-meshheading:2962073-Bronchi,
pubmed-meshheading:2962073-Chronic Disease,
pubmed-meshheading:2962073-Dose-Response Relationship, Drug,
pubmed-meshheading:2962073-Humans,
pubmed-meshheading:2962073-Ipratropium,
pubmed-meshheading:2962073-Middle Aged
|
pubmed:year |
1987
|
pubmed:articleTitle |
Anticholinergic therapy in chronic asthma.
|
pubmed:affiliation |
General Hospital, Southampton, UK.
|
pubmed:publicationType |
Journal Article,
Review
|